Pharmacyclics Overview
- Year Founded
-
1991
- Status
-
Acquired/Merged
- Employees
-
607
- Latest Deal Type
-
Later Stage VC
- Investors
-
1
Pharmacyclics General Information
Description
Developer of small-molecule drugs designed for the treatment of cancer and immune-mediated diseases. The company offers hematological oncology therapies, inhibitors, cancer treatment options, immune-mediated disease treatments, and clinical research programs, enabling healthcare providers to treat blood cancers and other serious conditions through innovative therapeutic discovery and clinical development.
Contact Information
Website
www.pharmacyclics.com(Operating Subsidiary)
Corporate Office
- 1000 Gateway Boulevard
- South San Francisco
- San Francisco, CA 94080
- United States
Corporate Office
- 1000 Gateway Boulevard
- South San Francisco
- San Francisco, CA 94080
- United States
Pharmacyclics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 01-Jul-2026 | Completed | Profitable | |||
| 4. Merger/Acquisition | 26-May-2015 | Completed | Profitable | |||
| 3. PIPE | 01-Aug-2006 | Completed | Generating Revenue/Not Profitable | |||
| 2. IPO | 24-Oct-1995 | $25.8M | $33.9M | Completed | Generating Revenue/Not Profitable | |
| 1. Early Stage VC | 22-Apr-1994 | $8.1M | $8.1M | Completed | Product Development |
Pharmacyclics Comparisons
Industry
Financing
Details
Pharmacyclics Competitors (46)
One of Pharmacyclics’s 46 competitors is Immunocore Holdings, a Formerly VC-backed company based in Abingdon, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immunocore Holdings | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Vertex Pharmaceuticals | Formerly VC-backed | Boston, MA | ||||
| Rein Therapeutics | Formerly VC-backed | Austin, TX | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Iovance Biotherapeutics | Corporation | San Carlos, CA |
Pharmacyclics Patents
Pharmacyclics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180194762-A1 | Pyrazolo[3,4-b]pyridine and pyrrolo[2,3-b]pyridine inhibitors of bruton's tyrosine kinase | Inactive | 06-Jan-2017 | ||
| WO-2017205762-A1 | Inhibitors of interleukin-1 receptor-associated kinase | Inactive | 27-May-2016 | ||
| WO-2017205766-A1 | Inhibitors of interleukin-1 receptor-associated kinase | Inactive | 27-May-2016 | ||
| WO-2017205769-A1 | Inhibitors of interleukin-1 receptor-associated kinase | Inactive | 27-May-2016 | ||
| WO-2017087947-A2 | Method of treatment of follicular lymphoma with a btk inhibitor | Inactive | 19-Nov-2015 | A61K31/519 |
Pharmacyclics Signals
Pharmacyclics Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Adams Street Partners | PE/Buyout | Minority | ||
| Alloy Ventures | Venture Capital | Minority | ||
| Asset Management Ventures | Venture Capital | Minority | ||
| BB Biotech | Asset Manager | Minority | ||
| Comdisco Ventures | Venture Capital | Minority |
Pharmacyclics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Pharmacyclics FAQs
-
When was Pharmacyclics founded?
Pharmacyclics was founded in 1991.
-
Where is Pharmacyclics headquartered?
Pharmacyclics is headquartered in San Francisco, CA.
-
What is the size of Pharmacyclics?
Pharmacyclics has 607 total employees.
-
What industry is Pharmacyclics in?
Pharmacyclics’s primary industry is Drug Discovery.
-
Is Pharmacyclics a private or public company?
Pharmacyclics is a Private company.
-
What is Pharmacyclics’s current revenue?
The current revenue for Pharmacyclics is .
-
How much funding has Pharmacyclics raised over time?
Pharmacyclics has raised $53.9M.
-
Who are Pharmacyclics’s investors?
Adams Street Partners, Alloy Ventures, Asset Management Ventures, BB Biotech, and Comdisco Ventures are 5 of 9 investors who have invested in Pharmacyclics.
-
Who are Pharmacyclics’s competitors?
Immunocore Holdings, Vertex Pharmaceuticals, Rein Therapeutics, Inovio Pharmaceuticals, and Iovance Biotherapeutics are some of the 46 competitors of Pharmacyclics.
-
When was Pharmacyclics acquired?
Pharmacyclics was acquired on 01-Jul-2026.
-
Who acquired Pharmacyclics?
Pharmacyclics was acquired by AbbVie.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process